Literature DB >> 6264257

A new approach to the treatment of atherosclerosis and trapidil as an antagonist to platelet-derived growth factor.

H Ohnishi, K Yamaguchi, S Shimada, Y Suzuki, A Kumagai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6264257     DOI： 10.1016/0024-3205(81)90320-9

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  10 in total

1.  Paracrine effect of human vascular endothelial cells on human vascular smooth muscle cell proliferation: transmembrane co-culture method.

Authors:  H Yoshida; M Nakamura; S Makita; K Hiramori
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

Review 2.  [Pathophysiologic significance of growth factors and new therapeutic concepts in cardiovascular disease].

Authors:  S Rosenkranz; M Böhm; A Kazlauskas
Journal:  Med Klin (Munich)       Date:  1999-09-15

3.  Trial of platelet-derived growth factor antagonist, trapidil, in accelerated nephrotoxic nephritis in the rabbit.

Authors:  Y Shinkai; J S Cameron
Journal:  Br J Exp Pathol       Date:  1987-12

4.  Synthesis, structure and biological evaluation of ruthenium(III) complexes of triazolopyrimidines with anticancer properties.

Authors:  Marzena Fandzloch; Liliana Dobrzańska; Tomasz Jędrzejewski; Julia Jezierska; Joanna Wiśniewska; Iwona Łakomska
Journal:  J Biol Inorg Chem       Date:  2019-11-18       Impact factor: 3.358

5.  Role of PDGF B-chain and PDGF receptors in rat tubular regeneration after acute injury.

Authors:  T Nakagawa; M Sasahara; M Haneda; H Kataoka; H Nakagawa; M Yagi; R Kikkawa; F Hazama
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 6.  Differential effects of intermittent and continuous administration of parathyroid hormone on bone histomorphometry and gene expression.

Authors:  Sutada Lotinun; Jean D Sibonga; Russell T Turner
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

7.  Effects of local delivery of trapidil on neointima formation in a rabbit angioplasty model.

Authors:  K Zacharowski; D Schneidmüller; W Ibe; T Grosser; M Buerke; J Meyer; H Darius
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

8.  Activation of Src kinase in platelet-derived growth factor-B-dependent tubular regeneration after acute ischemic renal injury.

Authors:  Mikiko Takikita-Suzuki; Masakazu Haneda; Masakiyo Sasahara; M Koji Owada; Takahiko Nakagawa; Motohide Isono; Shoichi Takikita; Daisuke Koya; Kazumasa Ogasawara; Ryuichi Kikkawa
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

9.  Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors.

Authors:  Jayesh Desai; Hui Gan; Catherine Barrow; Michael Jameson; Victoria Atkinson; Andrew Haydon; Michael Millward; Stephen Begbie; Michael Brown; Ben Markman; William Patterson; Andrew Hill; Lisa Horvath; Adnan Nagrial; Gary Richardson; Christopher Jackson; Michael Friedlander; Phillip Parente; Ben Tran; Lai Wang; Yunxin Chen; Zhiyu Tang; Wendy Huang; John Wu; Dewan Zeng; Lusong Luo; Benjamin Solomon
Journal:  J Clin Oncol       Date:  2020-03-17       Impact factor: 44.544

10.  Crosstalk between Cancer Cells and Fibroblasts for the Production of Monocyte Chemoattractant Protein-1 in the Murine 4T1 Breast Cancer.

Authors:  Mayu Imamura; Tiantian Li; Chunning Li; Masayoshi Fujisawa; Naofumi Mukaida; Akihiro Matsukawa; Teizo Yoshimura
Journal:  Curr Issues Mol Biol       Date:  2021-10-22       Impact factor: 2.976
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.